Centrus Energy walks into today's earnings print in a materially different position than it held a week ago — the stock has rallied 17.5% over five days to $187.63, yet the borrow market remains completely exhausted and short interest is barely off its recent high.
The borrow story is unchanged from last week's preview, but the price move has sharpened the tension. Availability has been at zero — every share in the lending pool already lent out — for nearly all of July and into August. Short interest remains near a monthly peak at 27.9% of the free float, with roughly 4.87 million shares short and 5.3 days to cover per the latest FINRA data. Cost to borrow has actually eased, falling 28% over the past week to just over 1%, which is consistent with a frozen pool rather than a market scrambling to find new supply. The ORTEX short score has climbed to 75.1, the highest reading in the available history, ranking in the 2nd percentile of the universe — meaning almost no stock carries a more bearish positioning profile. For shorts who were sitting at 27.7% of float last week, the stock's 17% run has added significant mark-to-market pain without giving them any exit route.
Options traders are not piling on with hedges. The put/call ratio is running at 0.65, slightly below its 20-day average of 0.68 and near the lower end of the 52-week range, which runs from 0.62 to 0.83. That call-heavy lean has persisted as the stock rallied — suggesting that some participants are positioned for further upside rather than bracing for a reversal. The divergence between zero borrow availability and relatively relaxed options positioning is the central tension in the setup: shorts are trapped with nowhere to cover, while call holders are riding a move that has already delivered strong gains into the number.
The analyst community is split and has been trimming targets. JP Morgan lowered its price target to $178 — below the current price — just eight days ago while keeping a Neutral rating, a notable signal from a bellwether firm that the recent rally has run past their fair value estimate. Truist Securities initiated with a Buy and a $215 target in mid-July, while BofA cut to $205. The mean target across the coverage is $259, well above where the stock trades, though that average is anchored by more bullish names like Needham ($264) and B. Riley ($295). Bulls point to the $900 million DOE award and the long-term domestic enrichment opportunity; bears focus on execution risk at the Piketon expansion, reliance on Russian LEU supply, and the absence of a concrete capital budget. Uranium peers were broadly strong on the week — UEC gained 11% and LTBR added 13% — suggesting the sector tailwind accounts for at least part of LEU's move.
The print will test whether the underlying contract revenue and margins justify a stock that has recovered strongly on sector momentum, or whether the operational uncertainties that drove 27.9% short interest were better-informed than the options market's call-side lean suggests.
See the live data behind this article on ORTEX.
Open LEU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
